Analysts think ILMN stock price could increase by 72%
Apr 04, 2025, 11:25 AM
1.98%
What does ILMN do
Illumina, headquartered in San Diego, develops life science tools for genetic analysis, employing 10,590 staff since its IPO in 2000. Its products span various applications, including oncology and agriculture.
26 analysts think ILMN stock price will increase by 72.25%. The current median analyst target is $131.58 compared to a current stock price of $76.39. The lowest analysts target is $90.90 and the highest analyst target is $199.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
